Evidence map›Paper›PMID 30939855›Full record

ReviewNutrients2019

Reversing Type 2 Diabetes: A Narrative Review of the Evidence.

Sarah J Hallberg, Victoria M Gershuni, Tamara L Hazbun, Shaminie J Athinarayanan

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04764279 (Rural-specific OPTIFAST Intervention - A Randomized Study for Partial Remission of Type 2 Diabetes in Patients With Obesity Between the Age of 18 and 65), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04764279 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Rural-specific OPTIFAST Intervention - A Randomized Study for Partial Remission of Type 2 Diabetes in Patients With Obesity Between the Age of 18 and 65

TypeinterventionalSponsorMarathon Family Health TeamRan2021 to 2022Enrolled30ConditionsDiabetes Mellitus, Type 2, ObesityArmsOPTIFAST dietary supplement
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 170 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Tailoring Exercise Prescription for Effective Diabetes Glucose Management.The Journal of clinical endocrinology and metabolism · 2025
    Review
  6. Article
  7. Article
  8. Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  9. Article
  10. Review
  11. Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit Analysis.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  12. Low-Carbohydrate and Ketogenic Dietary Patterns for Type 2 Diabetes Management.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2024
    Review
  13. Review
  14. Article
  15. Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sarah J HallbergVirta Health, 535 Mission Street, San Francisco, CA 94105, USA. sarah@virtahealth.com.
Victoria M GershuniDepartment of Surgery, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA 19104, USA. victoriagershunimd@gmail.com.
Tamara L HazbunIndiana University Health Arnett, Lafayette, IN 47904, USA. thazbun@iuhealth.org.
Shaminie J AthinarayananVirta Health, 535 Mission Street, San Francisco, CA 94105, USA. shaminie@virtahealth.com.
Indiana University Health · USUniversity of Pennsylvania · USVirtua Health · US

Funding

NRSA Training CoreTL1TR001880 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$10.0M
NCATS NIH HHS TL1 TR001880
6 · The paper itself

Abstract

backgroundType 2 diabetes (T2D) has long been identified as an incurable chronic disease based on traditional means of treatment. Research now exists that suggests reversal is possible through other means that have only recently been embraced in the guidelines. This narrative review examines the evidence for T2D reversal using each of the three methods, including advantages and limitations for each.

methodsA literature search was performed, and a total of 99 original articles containing information pertaining to diabetes reversal or remission were included.

resultsEvidence exists that T2D reversal is achievable using bariatric surgery, low-calorie diets (LCD), or carbohydrate restriction (LC). Bariatric surgery has been recommended for the treatment of T2D since 2016 by an international diabetes consensus group. Both the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) now recommend a LC eating pattern and support the short-term use of LCD for weight loss. However, only T2D treatment, not reversal, is discussed in their guidelines.

conclusionGiven the state of evidence for T2D reversal, healthcare providers need to be educated on reversal options so they can actively engage in counseling patients who may desire this approach to their disease.

Indexed as

Bariatric SurgeryCaloric RestrictionDiet, Carbohydrate-RestrictedDiabetes Mellitus, Type 2EuropeHumansWeight Lossbariatric surgerydiabetesdiabetes reversallow-carbohydratevery-low-calorie

Identifiers

PMID30939855
PMCPMC6520897
OpenAlexW2932484301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.